Methinks: Somebody’s just trying to depress Pfizer’s stock price, so they can come in and buy low when it tanks.
Biography: Peter A. McCullough, MD, MPH
Peter A. McCullough, MD, MPH
Professor of Medicine
Vice Chief of Internal Medicine
Baylor University Medical Center
Dallas, TX
After receiving a bachelor’s degree from Baylor University, Dr. McCullough completed his medical degree as an Alpha Omega Alpha graduate from the University of Texas Southwestern Medical School in Dallas. He went on to complete his internal medicine residency at the University of Washington in Seattle, cardiology fellowship including service as Chief Fellow at William Beaumont Hospital, and master’s degree in public health at the University of Michigan.
Dr. McCullough is a consultant cardiologist and Vice Chief of Medicine at Baylor University Medical Center in Dallas, TX. He is a Principal Faculty in internal medicine for the Texas A & M University Health Sciences Center.
Dr. McCullough is an internationally recognized authority on the role of chronic kidney disease as a cardiovascular risk state with > 1000 publications and > 500 citations in the National Library of Medicine. His works include the “Interface between Renal Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook.
Dr. McCullough is a recipient of the Simon Dack Award from the American College of Cardiology and the International Vicenza Award in Critical Care Nephrology for his scholarship and research.
Dr. McCullough is a founder and current president of the Cardiorenal Society of America, an organization dedicated to bringing cardiologists and nephrologists together to work on the emerging problem of cardiorenal syndromes. His works have appeared in the New England Journal of Medicine, Journal of the American Medical Association, Lancet and other top-tier journals worldwide. He is the co-editor of Reviews in Cardiovascular Medicine, and associate editor of the American Journal of Cardiology and Cardiorenal Medicine. He serves on the editorial boards of multiple specialty journals.
Dr. McCullough has made presentations on the advancement of medicine across the world and has been an invited lecturer at the New York Academy of Sciences, the National Institutes of Health, U.S. Food and Drug Administration (FDA), European Medicines Agency, and the U.S. Congressional Oversight Panel.
Major Contributions
Senior leadership and oversight of clinical, education, and research operations at major academic medical centers in Detroit, Kansas City, and Dallas
Led observational studies and randomized trials of therapies for acute kidney injury, hypertension, acute coronary syndromes, heart failure, and cardiorenal syndromes
Chaired and participated on 15 data safety monitoring committees for large randomized trials
Advised sponsors and the FDA resulting in approval of 15 new drugs and 3 novel in vitro diagnostic tests used today around the world
thanks, Cathi
My friend’s grandsons 1 1 and 14, caught Covid. They felt like they had a cold for four days. Now they have natural immunity. The family is happy about that.
Sponsoring FReepers are contributing
$10 Each time a New Monthly Donor signs up!
Get more bang for your FR buck!
Click Here To Sign Up Now!
May 28, 2021 VAERS data released today showed 262,521 reports of adverse events following COVID vaccines.
May 21, a total of 227,521 total adverse events were reported to VAERS.
This 35,000 increase from last week doesn’t represent just new reports. As I have posted before VAERS originally only had a capacity to publish 5-7,000 reports per week but they were receiving many multitudes of that. After a new 16 million dollar additional contract to General Dynamics they were able over a period of a few weeks to add enough capacity to handle 30,000+ reports per week.
They are still very much backlogged. It is going to be interesting to see how long it take them to get up to date.
“This week’s data showed 3,449 total adverse events, including 58 rated as serious, among 12- to -17-year-olds.”
Thank you for posting these important articles!